Herceptin (trastuzumab) is not considered immunosuppressive in the traditional sense. Instead, it is a targeted therapy used to treat HER2-positive Breast cancer by binding to the HER2 receptor on cancer cells, inhibiting their growth and promoting immune-mediated destruction of these cells. While it can impact the immune system's response to cancer, it does not broadly suppress immune function like typical immunosuppressive drugs. However, some patients may experience side effects that could affect immune responses indirectly.
yes, and u also lose your fingers
Medicare Part B will cover the cancer drug Herceptin.
I have a severe back pain. My last herceptin trtmnt was done three days ago.
1. Herceptin.
When receiving herceptin (trastuzumab), it's important to ask your doctor the following questions: How does herceptin work for my type of breast cancer? What are the potential side effects I should be aware of? How will this treatment affect my daily life? How often will I receive herceptin, and for how long? Are there any specific tests or monitoring I need during treatment? Can herceptin be combined with other treatments I’m receiving? What should I do if I experience side effects? Are there any dietary restrictions or lifestyle changes I should consider? How will we know if herceptin is working for me? Are there alternatives to herceptin that we should consider? What are the chances of recurrence after treatment? How will this treatment impact my fertility? What support resources are available for me during treatment? Are there clinical trials I might qualify for? What follow-up care will I need after finishing herceptin? These questions can help you understand the treatment and make informed decisions about your care.
yes
organ transplantation
Infections are a constant risk while on immunosuppressive agents, because the immune system is supposed to prevent them.
The duration of Herceptin (trastuzumab) treatment typically depends on the individual patient's cancer type and stage, as well as their response to the therapy. For early-stage HER2-positive breast cancer, it is often administered for about a year. In metastatic cases, Herceptin may be given for an extended period, as long as the cancer is responding to the treatment and the patient tolerates it well. Always consult with a healthcare provider for personalized recommendations.
Most definitely! My leg pain is to die for...
Increased risk for infection
They do! It is called Herceptin but could only cure Breast cancer.